Lumenis shareholders approve merger with XIO Fund I LP

Nasdaq GlobeNewswire reported that Lumenis Ltd. announced that the shareholders of Lumenis approved merger proposal at a special shareholders meeting held on August 3. According to the merger proposal Lumenis will become a wholly-owned subsidiary of an Israeli company that is, indirectly, wholly- owned by XIO Fund I LP. The merger with XIO is expected to close in September 2015.

Lumenis is the world's largest energy-based medical company for surgical, ophthalmology and aesthetic applications. XIO Group is a global multi-billion dollar alternative investments firm with offices in London, Hong Kong and Shanghai.

For more details: